B2M and neoplasm: On the whole, while the loss of one copy of B2M is relatively common across multiple cancers [16], a complete loss of B2M expression is uncommon [16,60,63,64,65], most likely because a complete loss of MHC-I makes the tumor susceptible to NK cell-mediated killing (more details in Section 4.2.1).